Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 3 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Amneal Pharmaceuticals Inc have a median target of 10.50, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a 26.20% increase from the last price of 8.32.
High | 44.2% | 12.00 |
Med | 26.2% | 10.50 |
Low | -15.9% | 7.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 12, 2025.
Average growth rate | -3.01% |
Average growth rate | +22.26% |
More ▼
Revenue history & estimates in USD
Average growth rate | +3.23% |
Average growth rate | +10.36% |
More ▼